HSBC’s Herald Van Der Linde said foreign investors continue to favour Taiwan and South Korea due to strong AI-driven earnings growth, leaving India temporarily out…

In absolute terms, Indian Bank’s Gross NPA declined to ₹14,268 crore from ₹16,134 crore, while Net NPA stood at ₹967 crore from ₹983 crore in…

Revenue saw a modest increase of 2.2% to ₹209 crore from ₹205 crore, pointing to subdued topline growth during the quarter.

Dipan Mehta, Director of Elixir Equities said Sky Gold and Diamonds offers exposure to the jewellery sector through its B2B model. As a key supplier…

Mitul Kotecha, Head of Forex & EM Macro Strategy for Asia at Barclays, said 92 is a key psychological level for the USD-INR pair, adding…

HSBC cited an earnings beat in Q3, with adjusted profit after tax coming in ahead of estimates, even as operating conditions remained challenging.

Zydus Lifesciences launched Tishtha™, the world’s first Nivolumab biosimilar in India, offering affordable cancer treatment and expanding access to advanced immuno-oncology therapies.

Before today’s trading session, Spot Silver prices were up 30%, while the Nippon Silver ETF had risen 45%.

Gold prices in Mumbai stayed firm as safe-haven buying persisted, while Gold ETFs like Birla Sun Life Gold ETF and Axis Gold ETF fell sharply…

The PNB Housing Finance management in its post-earnings conference call said the decline in affordable disbursements is due to certain pockets that were impacted due…